Epigenetic enzyme found to be lacking in some patients with Crohn's disease
Massachusetts General Hospital researchers have found how a variant in an important epigenetic enzyme – previously associated with Crohn’s disease and other immune disorders – interferes with the action of the innate immune system, potentially upsetting the balance between the microbial population of the gastrointestinal tract and the immune response.